Bayesian Pathway Enrichment Analysis
Also known as: Bayesian gene-set testing, Bayesian GSEA, Bayesian functional enrichment, BGSEA
Bayesian pathway enrichment analysis tests whether a predefined set of genes — a biological pathway — is systematically overrepresented among genes that show evidence of differential activity in an experiment. Unlike classical over-representation tests, it encodes prior biological knowledge as a prior distribution and updates it with the observed expression data, yielding posterior probabilities of enrichment rather than p-values. This probabilistic framing naturally handles small samples, multiple pathways, and uncertainty propagation in a coherent statistical framework.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use Bayesian pathway enrichment analysis when sample sizes are small (fewer than 6–10 replicates per group), making classical hypergeometric or permutation-based GSEA prone to instability; when you want to propagate uncertainty from differential expression into enrichment testing rather than treating fold-change estimates as known; or when you have genuine prior knowledge about pathway relevance that can be formally encoded. It also suits multi-condition experiments where a single probabilistic model can jointly test enrichment across conditions. Do NOT use it as a drop-in replacement for standard GSEA when large, well-powered datasets are available and a reproducible, tool-standardised result is required for regulatory submission — classical GSEA and its validated FDR procedures are the accepted norm in those contexts. Avoid it when pathway databases are not appropriate for the organism or tissue type under study, as the results will be meaningless regardless of the statistical framework.
Strengths & limitations
- Propagates uncertainty from gene-level expression estimates into pathway-level conclusions, avoiding the pretence that fold-change estimates are exact.
- Performs well under small sample sizes where permutation-based methods have insufficient power.
- Produces interpretable posterior probabilities of enrichment, eliminating dependence on an arbitrary p-value threshold.
- Can incorporate external biological prior knowledge (e.g., known driver pathways in a disease) to sharpen inference.
- Naturally handles the multiple-testing problem through Bayesian FDR without requiring the sharp null assumptions of classical corrections.
- Computationally intensive relative to classical hypergeometric or GSEA approaches, particularly for full hierarchical Bayesian models with MCMC sampling.
- Posterior inferences are sensitive to the choice of prior when data are sparse; results should always be accompanied by a prior sensitivity analysis.
- Fewer off-the-shelf software tools are available compared to the extensive ecosystem supporting classical GSEA (e.g., fgsea, clusterProfiler).
- Requires familiarity with Bayesian modelling concepts to specify the model, interpret credible intervals, and diagnose MCMC convergence.
Frequently asked
How does this differ from standard GSEA?
Standard GSEA (Subramanian et al., 2005) ranks genes by a correlation statistic, computes a running-sum enrichment score, and estimates significance by permutation. It produces a normalised enrichment score and an empirical p-value. Bayesian pathway enrichment analysis instead models expression data probabilistically, specifies a prior over enrichment, and outputs posterior probabilities. The Bayesian approach handles uncertainty more explicitly and performs better under small n, but GSEA is more widely implemented and accepted in standard genomics pipelines.
Which software implements Bayesian pathway enrichment?
The limma/ROAST framework (Bioconductor) uses a rotation-based empirical-Bayes approach for gene-set testing. The mroast and fry functions offer fast variants. Full hierarchical Bayesian implementations are available in bespoke R packages such as BayesGSEA and in Stan-based custom models. Most require R/Bioconductor familiarity.
How do I choose the prior?
An empirical-Bayes approach — estimating prior hyperparameters from the data — is the safest default when no strong external knowledge exists. If prior biological knowledge is available (e.g., known disease pathways), informative priors can be set on those pathway enrichment probabilities. Always report what prior was used and include a sensitivity analysis varying the prior to show how robust conclusions are to that choice.
Can I use this for single-cell RNA-seq data?
Yes, but single-cell data requires an additional aggregation step. The recommended approach is pseudo-bulk analysis: cells are aggregated by cell type and biological replicate to produce count matrices that behave like bulk RNA-seq, and Bayesian pathway testing is then applied to those pseudo-bulk profiles. Applying pathway tests directly to individual cells without aggregation inflates false positives due to sparse count data and artificial replication.
What pathway databases should I use?
KEGG, Reactome, and Gene Ontology Biological Process are the most commonly used curated databases and are available via the msigdb collections in R. The choice should match the biological question: KEGG for metabolic and signalling pathways, Reactome for mechanistic biochemical detail, GO BP for broader functional categories. Using all three simultaneously inflates the multiple-testing burden and requires careful Bayesian FDR handling.
Sources
- Baldi, P., & Long, A. D. (2001). A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics, 17(6), 509–519. DOI: 10.1093/bioinformatics/17.6.509 ↗
- Newton, M. A., Quintana, F. A., Den Boon, J. A., Bhattacharya, S., & Ahlquist, P. (2004). Random-set methods identify distinct aspects of the enrichment signal in gene-set analysis. The Annals of Applied Statistics, 1(1), 85–106. link ↗
How to cite this page
ScholarGate. (2026, June 3). Bayesian Pathway Enrichment Analysis. ScholarGate. https://scholargate.app/en/bioinformatics/bayesian-pathway-enrichment-analysis
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Bayesian RNA-seq differential expressionBioinformatics↔ compare
- eQTL AnalysisBioinformatics↔ compare
- Gene Set Enrichment AnalysisBioinformatics↔ compare
- Multi-omics Pathway Enrichment AnalysisBioinformatics↔ compare
- Network-based pathway enrichment analysisBioinformatics↔ compare
- Pathway Enrichment AnalysisBioinformatics↔ compare